Norfloxacin
Norfloxacin is a fluoroquinolone antibiotic used to treat certain bacterial infections, particularly urinary tract infections caused by susceptible organisms. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes required for bacterial DNA replication and repair. Norfloxacin is primarily available as oral tablets, although approved uses and availability vary by country. Common side effects include nausea, abdominal discomfort, diarrhoea, headache, and dizziness. Serious risks include tendon inflammation or rupture, peripheral neuropathy, central nervous system effects, and disturbances in blood glucose or heart rhythm. Because of these potentially severe adverse effects and increasing antibiotic resistance, norfloxacin should be used only when clinically appropriate, according to medical advice and local prescribing guidance.
Norfloxacin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Norfloxacin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Norfloxacin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Norfloxacin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
